Replies to post #103528 on Regen BioPharma Inc (RGBP)

[Mutat]

Mr Koos did not pay a company to value his company without a reason.

On Nov 15 Mr Koos had a Valuation Assessment of RGBP done by Biotech Research Group Mr Koos will have a price of what RGBP's actual Market Value is in a Buy Out situation. He will have a certified copy of his Company's value for the sale of RGBP. Just complete Canary merger sign the sale contracts and sail off in the Horizon and we are RICH.